Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement

Basit Öğe Kaydı
dc.authoridErdal Karaöz / 0000-0002-9992-833Xen_US
dc.authorscopusidErdal Karaöz / 7003448087
dc.authorwosidErdal Karaöz / IXE-6677-2023
dc.contributor.authorYılmaz, R.
dc.contributor.authorAdaş, G.
dc.contributor.authorÇukurova, Z.
dc.contributor.authorYaşar, Kart K.
dc.contributor.authorIşıksaçan, N.
dc.contributor.authorÖztel, O. N.
dc.contributor.authorKaraöz, Erdal
dc.date.accessioned2021-01-06T10:33:13Z
dc.date.available2021-01-06T10:33:13Z
dc.date.issued2020en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.description.abstractThe aim of this study is to evaluate the therapeutic effect of mesenchymal stem cells (MSCs) in a severe case of brain and multiple organ involvement in a patient with COVID-19. Here, a 51-year-old male patient with multi-organ involvement due to COVID-19 infection and developing cardiac arrest is presented. MSCs were transplanted to the patient four times systematically and once intrathecally. As a result, the application of MSCs has been found to have a healing effect on organs in this patient with severe COVID-19 infection. In addition, transplantation of MSCs both systematically and intrathecally is considered to be effective in the treatment of the central nervous system (Tab. 2, Fig. 2, Ref. 24). Text in PDF www.elis.sken_US
dc.identifier.citationYilmaz, R., Adas, G., Cukurova, Z., Isiksacan, N., Oztel, O. N., & Karaoz, E. (2020). Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement. Bratislavske lekarske listy, 121(12), 847-852.en_US
dc.identifier.doi10.4149/BLL_2020_139en_US
dc.identifier.endpage852en_US
dc.identifier.issn0006-9248en_US
dc.identifier.issn1336-0345en_US
dc.identifier.issue2en_US
dc.identifier.pmid33300352en_US
dc.identifier.scopus2-s2.0-85097916202en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage847en_US
dc.identifier.urihttps://doi.org/10.4149/BLL_2020_139
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1304
dc.identifier.volume121en_US
dc.identifier.wosWOS:000599640000003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorKaraöz, Erdal
dc.language.isoenen_US
dc.publisherCOMENIUS UNIVen_US
dc.relation.ispartofBRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMesenchymal Stem Cellen_US
dc.subjectCOVID-19en_US
dc.subjectOrgan Involvementen_US
dc.titleMesenchymal stem cells treatment in COVID-19 patient with multi-organ involvementen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
BLL_2020_12_847 (1).pdf
Boyut:
517.2 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Temel Tıp Bilimleri Bölümü Makale Koleksiyonu